论文部分内容阅读
乙胺碘呋酮的独特电生理作用欧洲已认识了十余年,但美国近年才开始注意,并初步证实了欧洲报告的临床应用效果。它可有效治疗室性及室上性快速心律失常,防止了70～95％的复发性室性过速,包括对传统药物二种以上治疗无效者,它明显降低了预激综合症伴室上性心动过速者的手术治疗需要。它抗心律失常确切效应仍不清楚,主要的电
The unique electrophysiological effects of amiodarone Europe has been recognized for more than ten years, but the United States only began to pay attention in recent years, and initially confirmed the clinical efficacy of the European report. It is effective in treating ventricular and supraventricular tachyarrhythmias and prevents 70-95% of recurrent ventricular tachycardia, including those who are ineffective in more than two traditional therapies, which significantly reduces the risk of pre-excitation syndrome Tachycardia surgical treatment needs. The exact effect of anti-arrhythmic remains unclear, the main electrical